REFERENCES
- Winderl L M, Silverman L K. Prenatal identification of a completely cystic internal sacrococcygeal teratoma (type IV). Ultrasound Obstet Gynecol 1997; 9: 425–428, [INFOTRIEVE], [CSA]
- Ballantyne J W. Teratologie. Williams & Nougate, City 1874
- Crussi F G, Wrinkler R F, Mirkin D L. Sacrococcygeal teratoma in infants and children. Arch Pathol Lab Med 1978; 102: 402–405, [CSA]
- Bilik R, Shandling B, Pope M, et al. Malignant benign neonatal sacrococcygeal teratoma. J Pediatr Surg 1993; 28: 1158–1160, [INFOTRIEVE], [CROSSREF], [CSA]
- Lubchenco L O, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 1966; 37: 403–408, [INFOTRIEVE], [CSA]
- Brenner W E, Edelman D A, Hendricks C H. A standard of fetal growth for the United States of America. Am J Obstet Gynecol 1976; 126: 555–564, [PUBMED], [INFOTRIEVE], [CSA]
- Murphy J J, Blair G K, Fraser G C. Coagulopathy associated with large sacrococcygeal teratomas. J Pediatr Surg 1992; 27: 1308–1310, [INFOTRIEVE], [CROSSREF], [CSA]
- Bond S J, Harrison M R, Schmidt K G, et al. Death due to high-output cardiac failure in fetal sacrococcygeal teratoma. J Pediatr Surg 1990; 25: 1287–1291, [INFOTRIEVE], [CROSSREF], [CSA]
- Kum C K, Wong Y C, Prabhakaram K. Management of fetal sacrococcygeal teratoma. Ann Acad Med 1993; 22: 377–380, [CSA]
- Holterman A, Filiatraut D, Lallier M, et al. The natural history of sacrococcygeal teratomas diagnosed through routine obstetric sonogram: a single institution experience. J Pediatr Surg 2000; 33: 899–903, [CROSSREF], [CSA]
- Heerema-McKenney A, Harrison M R, Bratton B, Farrell J, Zaloudek C. Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors. Am J Surg Pathol 2005; 29: 29–38, [INFOTRIEVE], [CROSSREF], [CSA]
- Brinker M R, Sheldin R G, Moynihan P C. Sacrococcygeal teratoma in children. J La State Med Soc 1989; 141: 26–31, [INFOTRIEVE], [CSA]
- Dewan P A, Davidson P M, Campbell P E. Sacrococcygeal teratoma: has chemotherapy improved survival. J Pediatr Surg 1987; 22: 274–227, [INFOTRIEVE], [CSA]
- Brewer J A, Tank E S. Yolk sac tumors and alpha-fetoprotein. Urology 1993; 42: 79–80, [INFOTRIEVE], [CROSSREF], [CSA]
- Han S J, Yoo S, Choi S H, Hwang E H. Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors. Pediatr Surg Int 1997; 12: 599–602, [INFOTRIEVE], [CSA]